B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S)

B6; 129S-Hba-a1/Hba-a2tm1(HBA1/HBA2)Bcgen Hbb-bs/Hbb-bttm1(HBG1/hHBG2/hHBD/hHBB)Bcgen /Bcgen • 113687

B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S)

Product nameB-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S)
Catalog number113687
Strain nameB6; 129S-Hba-a1/Hba-a2tm1(HBA1/HBA2)Bcgen Hbb-bs/Hbb-bttm1(HBG1/hHBG2/hHBD/hHBB)Bcgen /Bcgen
Strain backgroundB6;129S
NCBI gene ID3039,3040,3047,3048,3043,3045 (Human)
AliasesHBH; ECYT7; HBA-T3; METHBA; HBH; ECYT7; HBA-T2; HBGA; HBGR; HBG-T2; HSGGL1; PRO2979; TNCY; HBG-T1; ECYT6; CD113t-C; beta-globin; HBK

このページで

  • Description
  • Targeting strategy
  • Phenotypic analysis

ポスター

すべて表示

    出版物

      Description
      • Background: Hemoglobin, a tetrameric protein in red blood cells, is genetically encoded by the α-globin gene cluster located on human chromosome 16 and the β-globin gene cluster on chromosome 11, with the coordinated expression of these gene clusters ensuring the balanced synthesis of α and β globin chains.Genetic mutations or deletions in the α- or β-globin gene clusters are closely linked to various hematological disorders: point mutations in the β-globin gene cause sickle cell anemia, while gene deletions or mutations leading to imbalanced globin chain synthesis result in thalassemia.
      • Gene editing strategy: The mouse's Hba-a1/Hba-a2 genes were replaced with human hHBA1/HBA2 in B-hHBA1/hHBA2 mice(129S2). The mouse's Hbb-bs/Hbb-bt genes were replaced with human hHBG1/hHBG2/hHBD/hHBB in B-hHBG1/hHBG2/hHBD/hHBBs mice. B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) were obtained by mating B-hHBA1/hHBA2 mice(129S2) and B-hHBG1/hHBG2/hHBD/hHBB mice.
      • mRNA expression analysis: Mouse Hba mRNA was exclusively detectable in wild-type mice but not in homozygous B-hHBA1/hHBA2 mice(129S2). Human HBA1 and HBA2 mRNA was exclusively detectable in homozygous B-hHBA1/hHBA2 mice(129S2). HBG1, HBG2, HBD and HBB mRNA were exclusively detectable in heterozygous B-hHBG1/hHBG2/hHBD/hHBB mice but not in wild-type mice.
      • The complete blood count and biochemical test results showed no significant differences in homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) compared with the wild-type C57BL/6JNifdc mice. The blood smear analysis exhibited normal red blood cell morphology in homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S).
      • Application: This product is used for pharmacodynamics and safety evaluation of cardiovascular diseases such as hemoglobinopathy, thalassemia and sickle cell disease
      Targeting strategy

      Gene targeting strategy for B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S).

      1.The mouse's Hba-a1/Hba-a2 genes were replaced with human HBA1/HBA2 in B-hHBA1/hHBA2 mice(129S2).

      2. The mouse's Hbb-bs/Hbb-bt genes were replaced with human HBG1/hHBG2/hHBD/hHBB in B-hHBG1/hHBG2/hHBD/hHBB mice.

      B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) were obtained by mating B-hHBA1/hHBA2 mice(129S2) and B-hHBG1/hHBG2/hHBD/hHBB mice

      mRNA expression analysis

      Strain specific analysis of HBA1 and HBA2 mRNA expression in wild-type 129S mice and homozygous B-hHBA1/hHBA2 mice(129S2) by RT-PCR. Spleen RNA was isolated from wild-type 129S mice (+/+) and homozygous B-hHBA1/hHBA2(129S2) (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with human HBA1 and HBA2 primers. Mouse Hba mRNA was exclusively detectable in wild-type mice but not in homozygous B-hHBA1/hHBA2 mice(129S2). Human HBA1 and HBA2 mRNA were exclusively detectable in homozygous B-hHBA1/hHBA2 mice(129S2).

      Strain specific analysis of HBB mRNA expression in wild-type C57BL/6JNifdc mice and heterozygous B-hHBG1/hHBG2/hHBD/hHBB mice by RT-PCR. Spleen RNA was isolated from wild-type C57BL/6JNifdc mice (+/+) and heterozygous B-hHBG1/hHBG2/hHBD/hHBB mice (H/+), then cDNA libraries were synthesized by reverse transcription, followed by PCR with human HBG1, HBG2, HBD and HBB primers. mGapdh was detected as internal control. HBG1, HBG2, HBD and HBB mRNA were exclusively detectable in heterozygous B-hHBG1/hHBG2/hHBD/hHBB mice but not in wild-type mice.

      Hematology analysis

      Complete blood count (CBC) of wild-type C57BL/6JNifdc mice, homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) and homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBBs mice(B6; 129S). Values are expressed as mean ± SD.

      Biochemistry analysis

      Biochemical test of wild-type C57BL/6JNifdc mice, homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) and homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBBs mice(B6; 129S). Values are expressed as mean ± SD.

      Blood smear analysis

      Blood smear analysis in wild-type C57BL/6JNifdc mice, homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) and homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBBs mice(B6; 129S). The blood smear analysis results showed that the homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) exhibited normal red blood cell morphology.

      Spleen analysis

      Spleen analysis in wild-type C57BL/6JNifdc mice, homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) and homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBBs mice(B6; 129S). No significant differences were observed in the spleen size between homozygous B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S) and wild-type C57BL/6JNifdc mice.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hHBA1/hHBA2/hHBG1/hHBG2/hHBD/hHBB mice(B6; 129S)] (Cat# 113687) was purchased from Biocytogen.